Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ValiRx PLC (GB:VAL)
LSE:VAL
Holding GB:VAL?
Track your performance easily
VAL Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range1.20p - 13.50p
Previous Close1.55p
Volume1.22M
Average Volume (3M)834.71K
Market Cap
£1.82M
Enterprise Value495.49K
Total Cash (Recent Filing)£1.14M
Total Debt (Recent Filing)£37.71K
Price to Earnings (P/E)―
Beta-0.38
Next Earnings
Apr 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding132,348,673
10 Day Avg. Volume277,885
30 Day Avg. Volume834,710
Standard Deviation0.39
R-Squared0.00979
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)83.75
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ValiRx plc News
PremiumCompany Announcements
ValiRx Secures Funding for Prostate Cancer Research
PremiumCompany Announcements
ValiRx Extends Licensing Option for Cancer Treatment
PremiumCompany Announcements
ValiRx Subsidiary Secures Key Contract with Amply
PremiumCompany Announcements
ValiRx Marks Milestone with New Product Launch
PremiumCompany Announcements
ValiRx Extends Exclusivity Agreement with TheoremRxPremiumCompany Announcements
ValiRx plc Announces Board Changes Amid Strategic Focus
PremiumCompany Announcements
ValiRx plc to Reveal Future Strategies in CEO Webinar
PremiumCompany Announcements
ValiRx Expands European Presence with BioRep PartnershipOptions Prices
Currently, No data available
---
Ownership Overview
VAL FAQ
What was ValiRx PLC’s price range in the past 12 months?
ValiRx PLC lowest share price was 1.20p and its highest was 13.50p in the past 12 months.
What is ValiRx PLC’s market cap?
Currently, no data Available
When is ValiRx PLC’s upcoming earnings report date?
ValiRx PLC’s upcoming earnings report date is Apr 15, 2025 which is in 144 days.
How were ValiRx PLC’s earnings last quarter?
ValiRx PLC released its earnings results on Sep 27, 2024. The company reported -0.007p earnings per share for the quarter, missing the consensus estimate of N/A by -0.007p.
Is ValiRx PLC overvalued?
According to Wall Street analysts ValiRx PLC’s price is currently Overvalued.
Does ValiRx PLC pay dividends?
ValiRx PLC does not currently pay dividends.
What is ValiRx PLC’s EPS estimate?
ValiRx PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ValiRx PLC have?
ValiRx PLC has 132,348,680 shares outstanding.
What happened to ValiRx PLC’s price movement after its last earnings report?
ValiRx PLC reported an EPS of -0.007p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -14.706%.
Which hedge fund is a major shareholder of ValiRx PLC?
Currently, no hedge funds are holding shares in GB:VAL
---
ValiRx plc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-85.90%
12-Months-Change
Fundamentals
Return on Equity
-49.01%
Trailing 12-Months
Asset Growth
-9.33%
Trailing 12-Months
Company Description
ValiRx PLC
ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in the epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, NAV3 for the cancer screening test, and VAL401 for lung cancer.
---
Technical Analysis
---